News

Saturday was the day to enjoy and experiment in the Hospitalet science park

This year within the framework of the Hospitalet Spring Festival, we enjoyed again in the Science Park.

Leer más about Saturday was the day to enjoy and experiment in the Hospitalet science park

We launch VacunAcció: a project to immunize against fake news

IDIBELL and the Virolai school, together in a new educational initiative of the Escolab program of the Barcelona City Council

Leer más about We launch VacunAcció: a project to immunize against fake news

IDIBELL and Bellvitge Hospital lead a study on the effectiveness of icatibant against COVID-19

Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital had launched a clinical study, along with the pharmaceutical company Takeda, to evaluate the efficacy and safety of Icatibant as a treatment against COVID-19.

Leer más about IDIBELL and Bellvitge Hospital lead a study on the effectiveness of icatibant against COVID-19

Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae

The work of the Epidemiology of Bacterial Infections research group of IDIBELL and HUB indicates that the bacteria could achieve the resistance through the acquisition of mobile DNA fragments.

Leer más about Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae

IDIBELL celebrates the Kickoff Meeting on Health Research Projects awarded by ISCIII

Last Tuesday, April 20th, within the Areté Training Program, the IDIBELL AES-2020 Kick Off Meeting was held, aimed at all researchers who have obtained a health research project within the “2020 AES Call” funded by the ISCIII.

Leer más about IDIBELL celebrates the Kickoff Meeting on Health Research Projects awarded by ISCIII

Confirmed the presence of autoantibodies against type 1 interferon as an indicator of COVID-19 poor prognosis

A study led by IDIBELL and the Infanta Eleonor University Hospital in Madrid shows that 10% of patients with severe COVID-19 present neutralizing antibodies against the cytokine interferon type 1.

Leer más about Confirmed the presence of autoantibodies against type 1 interferon as an indicator of COVID-19 poor prognosis

Discovery of Epigenetic Factors. Predicting the Severity of COVID-19

We found that there were epigenetic variations, the chemical switches that regulate DNA activity, in the individuals positive for the virus who developed a severe COVID-19.

Leer más about Discovery of Epigenetic Factors. Predicting the Severity of COVID-19

Created the largest public database of genetic variants that regulate the expression of genes in the colon to date

The study has also permitted identify genetic variants that modify the expression of genes in the colon and that are associated with diseases such as colorectal cancer, but also with other organs such as the brain, showing the relationship between the intestine and the brain.

Leer más about Created the largest public database of genetic variants that regulate the expression of genes in the colon to date

Voice analysis with artificial intelligence models may allow early detection of bulbar involvement in ALS

An investigation by the International Center for Numerical Methods in Engineering (CIMNE) and the University of Lleida (UdL), in which IDIBELL and the Hospital de Bellvitge has participated, has developed automated voice markers to identify early affectations of the disease.

Leer más about Voice analysis with artificial intelligence models may allow early detection of bulbar involvement in ALS
Scroll to Top